Biomarker Correlates With Survival for Pediatric Ebola Patients
By LabMedica International staff writers Posted on 08 Oct 2014 |
Outbreaks of Ebola virus disease (EVD) occur sporadically in Africa and are associated with high case-fatality rates yet children have been less affected than adults.
The term hemorrhagic fever has been used to describe this disease process because hemorrhagic manifestations develop in many patients during the course of illness which is characterized by abrupt onset of fever, fatigue, headache, myalgia, and gastrointestinal distress 3 to 13 days after exposure to the virus.
A team of scientists at Emory University (Atlanta, GA, USA) obtained serum samples 55 pediatric and 161 adult laboratory-confirmed cases from an outbreak in Gulu district (Uganda) that occurred in 2000 and 2001. The team used a series of multiplex assays to measure the concentrations of 55 serum analytes in specimens from patients from that outbreak to identify biomarkers specific to pediatric disease.
The 26-plex bead-based assay (Affymetrix; Santa Clara, CA, USA) was performed for chemokines and cytokines as well as a 2-plex assay for D-dimer and tissue plasminogen activator. Single-plex assays for ferritin and cortisol and 2-plex assays for tissue factor (TF) and thrombomodulin (Millipore; Billerica, MA, USA) were also implemented. Enzyme-linked immunosorbent assays (ELISA) were used to quantify mannose-binding lectin (Hycult Biotech; Plymouth Meeting, PA, USA) and total immunoglobulin G (IgG) (eBioscience; San Diego, CA, USA). A Piccolo comprehensive metabolic reagent disk was run on the Piccolo Xpress Chemistry Analyzer (Abaxis; Union City, CA, USA) to determine serum chemistry values.
Pediatric patients who survived had higher levels of the chemokine regulated on activation, normal T-cell expressed and secreted marker and lower levels of plasminogen activator inhibitor 1, soluble intracellular adhesion molecule, and soluble vascular cell adhesion molecule than did pediatric patients who died. Adult patients had similar levels of these analytes regardless of outcome. The regulated on activation, normal T cell expressed and secreted chemokine (RANTES), also known as Chemokine (C-C motif) ligand 5, was the only factor studied that demonstrated an association with higher survival rates in children.
The authors concluded that different pathophysiologic mechanisms of disease may be at work in pediatric patients, and children may benefit from different treatment than their adult counterparts. Therapeutic interventions targeted at decreasing endothelial activation in pediatric patients early during the course of infection might include drugs that affect endothelial activation, such as statins. The study was published in the October 2014 issue of the journal Emerging Infectious Diseases.
Related Links:
Emory University
Affymetrix
Abaxis
The term hemorrhagic fever has been used to describe this disease process because hemorrhagic manifestations develop in many patients during the course of illness which is characterized by abrupt onset of fever, fatigue, headache, myalgia, and gastrointestinal distress 3 to 13 days after exposure to the virus.
A team of scientists at Emory University (Atlanta, GA, USA) obtained serum samples 55 pediatric and 161 adult laboratory-confirmed cases from an outbreak in Gulu district (Uganda) that occurred in 2000 and 2001. The team used a series of multiplex assays to measure the concentrations of 55 serum analytes in specimens from patients from that outbreak to identify biomarkers specific to pediatric disease.
The 26-plex bead-based assay (Affymetrix; Santa Clara, CA, USA) was performed for chemokines and cytokines as well as a 2-plex assay for D-dimer and tissue plasminogen activator. Single-plex assays for ferritin and cortisol and 2-plex assays for tissue factor (TF) and thrombomodulin (Millipore; Billerica, MA, USA) were also implemented. Enzyme-linked immunosorbent assays (ELISA) were used to quantify mannose-binding lectin (Hycult Biotech; Plymouth Meeting, PA, USA) and total immunoglobulin G (IgG) (eBioscience; San Diego, CA, USA). A Piccolo comprehensive metabolic reagent disk was run on the Piccolo Xpress Chemistry Analyzer (Abaxis; Union City, CA, USA) to determine serum chemistry values.
Pediatric patients who survived had higher levels of the chemokine regulated on activation, normal T-cell expressed and secreted marker and lower levels of plasminogen activator inhibitor 1, soluble intracellular adhesion molecule, and soluble vascular cell adhesion molecule than did pediatric patients who died. Adult patients had similar levels of these analytes regardless of outcome. The regulated on activation, normal T cell expressed and secreted chemokine (RANTES), also known as Chemokine (C-C motif) ligand 5, was the only factor studied that demonstrated an association with higher survival rates in children.
The authors concluded that different pathophysiologic mechanisms of disease may be at work in pediatric patients, and children may benefit from different treatment than their adult counterparts. Therapeutic interventions targeted at decreasing endothelial activation in pediatric patients early during the course of infection might include drugs that affect endothelial activation, such as statins. The study was published in the October 2014 issue of the journal Emerging Infectious Diseases.
Related Links:
Emory University
Affymetrix
Abaxis
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia